Insulet Corp to Discuss Omnipod® 5 Pivotal Data - Conference Call Transcript
Good afternoon, everyone.
I'm Deb Gordon, Vice President of Investor Relations.
And thank you for joining us today for Insulet's investor webcast to discuss our Omnipod 5 pivotal trial results that were just presented a little while ago at ENDO 2021.
A PDF of the data that we're presenting today as well as a replay of this event will be available on our investor relations website.
Today's event will last about an hour, starting with prepared remarks, followed by a Q&A session. Dr. Trang Ly, our Senior Vice President and Medical Director, will present the Omnipod 5 pivotal data, followed by a discussion with Dr. Bruce Bode. And we're very excited to have Dr. Bode join us today. Not only is he principal investigator for our Omnipod 5 pivotal trial. He's principal investigator for our type 2 study, and he's also been involved in the research for all of the systems. Dr. Bode is a diabetes specialist with Atlanta Diabetes association and clinical associate professor in the Department of Medicine at Emory University.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |